Innova Captab Limited (NSE:INNOVACAP)
India · Delayed Price · Currency is INR 673.25
-5.60 (-0.82%)
Feb 16, 2026, 11:45 AM IST
Innova Captab Revenue
Innova Captab had revenue of 4.50B INR in the quarter ending December 31, 2025, with 42.29% growth. This brings the company's revenue in the last twelve months to 14.97B, up 25.63% year-over-year. In the fiscal year ending March 31, 2025, Innova Captab had annual revenue of 12.44B with 15.02% growth.
Revenue (ttm)
14.97B
Revenue Growth
+25.63%
P/S Ratio
2.60
Revenue / Employee
9.36M
Employees
1,600
Market Cap
38.85B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 12.44B | 1.62B | 15.02% |
| Mar 31, 2024 | 10.81B | 1.55B | 16.72% |
| Mar 31, 2023 | 9.26B | 1.26B | 15.72% |
| Mar 31, 2022 | 8.01B | 3.90B | 94.94% |
| Mar 31, 2021 | 4.11B | 373.42M | 10.00% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Strides Pharma Science | 47.26B |
| Akums Drugs and Pharmaceuticals | 43.19B |
| Alivus Life Sciences | 25.12B |
| Aarti Pharmalabs | 18.01B |
| Indoco Remedies | 17.60B |
| Solara Active Pharma Sciences | 12.55B |
| Windlas Biotech | 8.68B |
| Orchid Pharma | 8.11B |